Maravai LifeSciences Holdings, Inc. (MRVI)

NASDAQ: MRVI · Real-Time Price · USD

4.850

+0.910 (23.10%)

At close: May 8, 2026, 4:00 PM EDT

4.720

-0.130 (-2.68%)

After-hours: May 8, 2026, 7:58 PM EDT

MRVI Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	165.92	216.89	322.4	574.96	632.14	551.27
Cash & Short-Term Investments	165.92	216.89	322.4	574.96	632.14	551.27
Cash Growth	-41.79%	-32.73%	-43.93%	-9.04%	14.67%	133.41%
Accounts Receivable	33.42	25.5	38.52	54.61	138.62	117.51
Other Receivables	-	-	-	-	8.19	-
Total Trade Receivables	33.42	25.5	38.52	54.61	146.81	117.51
Inventory	40.46	40.5	50.08	51.4	43.15	51.56
Other Current Assets	11.94	13.37	18.15	18.95	25.8	19.7
Total Current Assets	251.74	296.25	429.15	699.91	847.9	740.04
Net Property, Plant & Equipment	146.93	151.48	164.47	162.9	52.69	46.33
Other Intangible Assets	144.89	151.54	194.96	220.99	216.66	117.57
Goodwill	129.43	129.43	159.88	326.03	283.67	152.77
Other Long-Term Assets	40.24	41.88	59.79	77.62	881.39	861.57
Total Assets	713.22	770.58	1,008	1,487	2,282	1,918
Accounts Payable	8.54	2.91	11.96	10.73	5.99	8.15
Accrued Expenses	28.65	36.57	39.57	60.24	53.37	34.57
Current Portion of Long-Term Debt	5.44	5.44	5.44	5.44	5.44	6
Current Portion of Leases	-	-	-	0.63	-	-
Unearned Revenue	-	-	-	3.36	3.09	10.21
Other Current Liabilities	-	-	-	7.07	42.25	34.84
Total Current Liabilities	42.62	44.92	56.97	87.47	110.14	93.78
Long-Term Debt	235.57	286.33	290.49	518.71	522	524.59
Long-Term Leases	29.87	30.14	31.11	31.9	-	-
Other Long-Term Liabilities	36.07	36.48	52.47	59.49	744.93	754.55
Total Long-Term Liabilities	301.51	352.95	374.06	610.1	1,267	1,279
Total Liabilities	344.13	397.87	431.04	697.57	1,377	1,373
Common Stock	2.58	2.56	2.53	2.51	2.55	2.55
Additional Paid-in Capital	202.13	199.18	181.87	128.5	137.9	128.39
Accumulated Other Comprehensive Income	0.47	0.52	-	-	-	-
Retained Earnings	6.39	10.12	140.89	285.74	404.77	184.56
Total Common Shareholders' Equity	211.56	212.38	325.29	416.75	545.22	315.5
Minority Interest	157.52	160.33	251.92	373.13	360.03	229.86
Shareholders' Equity	369.08	372.71	577.21	789.88	905.24	545.36
Total Liabilities & Equity	713.22	770.58	1,008	1,487	2,282	1,918
Total Debt	270.88	321.91	327.04	556.68	527.44	530.59
Net Cash (Debt)	-104.96	-105.02	-4.64	18.29	104.7	20.68
Net Cash Growth	-	-	-	-82.54%	406.27%	-
Net Cash Per Share	-0.72	-0.73	-0.03	0.14	0.41	0.08
Book Value	211.56	212.38	325.29	416.75	545.22	315.5
Book Value Per Share	1.45	1.47	2.36	3.16	2.14	1.22
Tangible Book Value	-62.75	-68.59	-29.54	-130.26	44.89	45.16
Tangible Book Value Per Share	-0.43	-0.48	-0.21	-0.99	0.18	0.18

Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q